GL1X · GenesisL1 explorer

Research workbench

Human glycinamide ribonucleotide transformylase domain at pH 8.5

Analyse Human glycinamide ribonucleotide transformylase domain at pH 8.5 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1MEJ
Type
protein
Length
603 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphoribosylglycinamide formyltransferase
EC
2.1.2.2
UniProt
P22102
Ligands
PO4
Pockets
5 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, A, CPhosphoribosylglycinamide formyltransferase (EC 2.1.2.2)protein20136% helix, 24% strandP22102

Ligands and binding sites

  • PO4 · Phosphate ion · ion · chains B
  • GOL · Glycerol · additive · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17240.720.7868GOL
26780.700.7861GOL
34370.650.7845PO4
43980.610.7646empty
51230.370.7314empty

Interfaces

3 interfaces between chains.

  • A–C · 694 Ų buried · 12 hydrogen bonds · protein-protein
  • B–C · 276 Ų buried · 3 hydrogen bonds · protein-protein
  • B–A · 94 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 1MEJ · Human Glycinamide Ribonucleotide Transformylase domain at pH 8.5 · the same entry in another collection · chain B against B, TM-score 1.00
  • P22102 · AlphaFold monomer V2.0 prediction for trifunctional purine biosynthetic protein… · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.